55 /100
HIGH RISK
Score updated Jul 14, 2026

HAO — Haoxi Health Technology Limited Dilution Risk Tracker

Track HAO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HAO — Get alerts when the score changes →

As of July 14, 2026, Haoxi Health Technology Limited (HAO) has a DilutionWatch DilutionScore of 55/100, rated HIGH dilution risk. Haoxi Health Technology Limited has a market capitalization of $2.00M, 2.40M shares outstanding, 5 institutional holders tracked. Key dilution vectors include approximately 24 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
85
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for HAO.
🔔 Track HAO — Get forecast alerts →

💹 Market Data

Market Cap$2.00M
Shares Outstanding2.40M
Float395.2K
Cash$6.66M
Debt$607.7K
Short InterestN/A

🏛 Institutional Holdings

5 institutional holders · 43.4K shares
#1 Xtx Topco Ltd 16.0K shares
#2 Two Sigma Securities, LLC 14.7K shares
#3 Susquehanna International Group, LLP 12.2K shares
+ 2 more holders Sign up free to view →

📉 Short Interest

Short Interest59.8K
Days to Cover1.0
% of Float15.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jun 30, 2025
4 INSIDER TRANSACTION May 20, 2026
6-K 8K EVENT May 19, 2026
6-K 8K EVENT May 13, 2026
3 FORM3 Apr 06, 2026
Full SEC filing analysis available with free account

📰 Recent News

📋 What This Means for HAO Shareholders

Haoxi Health Technology Limited (HAO) has a DilutionScore of 55/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch's EDGAR monitoring for HAO shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for HAO in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for HAO alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track HAO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HAO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for HAO
📊 HAO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HAO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.